US FDA's Spikevax Review By The Numbers

 
• By Sue Sutter
  
Drug Review Profile: Spikevax Chronology
Moderna's COVID-19 vaccine moved from pre-IND meeting to full approval in less than two years. • Source: Alamy

More from Drug Review Profiles

More from Product Reviews